BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18006767)

  • 1. Distribution patterns of dendritic cells and T cells in diffuse large B-cell lymphomas correlate with prognoses.
    Chang KC; Huang GC; Jones D; Lin YH
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6666-72. PubMed ID: 18006767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: role of maturation status and intratumoral localization.
    Sandel MH; Dadabayev AR; Menon AG; Morreau H; Melief CJ; Offringa R; van der Burg SH; Janssen-van Rhijn CM; Ensink NG; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Clin Cancer Res; 2005 Apr; 11(7):2576-82. PubMed ID: 15814636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
    Ait-Tahar K; Liggins AP; Collins GP; Campbell A; Barnardo M; Lawrie C; Moir D; Hatton C; Banham AH; Pulford K
    Br J Haematol; 2009 Aug; 146(4):396-407. PubMed ID: 19552722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer.
    Eisenthal A; Polyvkin N; Bramante-Schreiber L; Misonznik F; Hassner A; Lifschitz-Mercer B
    Hum Pathol; 2001 Aug; 32(8):803-7. PubMed ID: 11521223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
    Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
    Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between dendritic cells and memory T lymphocytes in tumor site and prognosis of hepatocellular carcinoma].
    Cai XY; Qiu SJ; Wu ZQ; Ye SL; Fan J; Zhou J; Tang ZY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):671-5. PubMed ID: 15932729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotype analysis of dendritic cells and lymphocytes associated with cutaneous malignant melanomas.
    García-Plata D; Lessana-Leibowitch M; Palangie A; Gulliemette J; Sedel D; Méndez L; Mozos E
    Invasion Metastasis; 1995; 15(3-4):125-34. PubMed ID: 8621268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
    Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
    Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation.
    Qi SN; Li YX; Wang H; Wang WH; Jin J; Song YW; Wang SL; Liu YP; Zhou LQ; Yu ZH
    Cancer; 2009 Nov; 115(21):4980-9. PubMed ID: 19634158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
    J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
    Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement.
    Le Gouill S; Talmant P; Touzeau C; Moreau A; Garand R; Juge-Morineau N; Gaillard F; Gastinne T; Milpied N; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2007 Oct; 92(10):1335-42. PubMed ID: 18024371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
    Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
    Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary diffuse large B-cell lymphomas of the bone: prognostic relevance of protein expression and clinical factors.
    Adams H; Tzankov A; d'Hondt S; Jundt G; Dirnhofer S; Went P
    Hum Pathol; 2008 Sep; 39(9):1323-30. PubMed ID: 18614198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with localized primary non-tonsillar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite a non-germinal center B-cell-like phenotype.
    Sato Y; Onishi N; Morito T; Takata K; Mizobuchi K; Nagatsuka H; Ichimura K; Tanaka T; Tamura M; Yoshino T
    Cancer Sci; 2009 Jan; 100(1):42-6. PubMed ID: 19018759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC; Muris JJ; Giroth CP; Vos W; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Histopathology; 2008 Apr; 52(5):578-84. PubMed ID: 18312353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reassessment of the prognostic factors of international prognostic index (IPI) in the patients with diffuse large B-cell lymphoma in an era of R-CHOP in Chinese population.
    Yang S; Yu Y; Jun-Min L; Jian-Qing M; Qiu-Sheng C; Yu C; Wei-Li Z; Jian-Hua Y; Hui-Jin Z; Yan W; Li W; Shu C; Zhi-Xiang S
    Ann Hematol; 2009 Sep; 88(9):863-9. PubMed ID: 19205655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.